Global Vision selected by Pfizer for worldwide deployment of automated proofreading solutions
Global Vision, the industry leader in the development of automated proofreading solutions has been selected by Pfizer for worldwide deployment as its proofreading technology solution. This deployment enables Pfizer to drive consistency, reduce costs and subjectivity for artwork and labeling verification throughout the packaging workflow process.
With a goal to identify, recommend and implement a global harmonized proofreading technology, a project team was formed within Pfizer to evaluate different technologies that could enhance packaging quality. Global Vision’s best-in-class text, artwork, print and barcode technologies were selected by Pfizer to provide complete inspection end-to-end: Docu-Proof – text verification and comparison for Regulatory Affairs; Digital-Page – artwork & proof revision comparator; ScanTVS – print inspection system and BarProof – barcode decoder and verification.
“Protecting your brands integrity is the lifeblood of a company’s continued success,” explained Reuben Malz, president of Global Vision. “As a global pharmaceutical leader, Pfizer’s decision to deploy Global Vision’s suite of inspection solutions will help ensure that the high quality control standards, that are synonymous with Pfizer, are maintained.”
Global Vision is the world leader in the design and delivery of automated proofreading solutions. Its complete suite of advanced solutions featuring text based, pixel-based and Braille inspection technologies are designed to eliminate printed artwork, text verification, and text comparison related errors, providing end-to end security at every stage of the workflow process.